 Eyepoint Pharmaceuticals NASDAQ:EYPTs stock had its hold rating restated by research analysts at HC Wainwright in a note issued to investors on Thursday, TipRanks reports. EYPT has been the topic of a number of other reports. Zacks Investment Research upgraded shares of Eyepoint Pharmaceuticals from a sell rating to a hold rating in a research ... 